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The ArmAssist is a simple low-cost robotic system for upper limb motor training that combines known benefits of repetitive task-
oriented training, greater intensity of practice, and less dependence on therapist assistance.The aim of this preliminary study was to
compare the efficacy ofArmAssist (AA) robotic training againstmatched conventional arm training in subacute stroke subjects with
moderate-to-severe upper limb impairment. Twenty-six subjects were enrolled within 3 months of stroke and randomly assigned
to the AA group or Control group (𝑛 = 13 each). Both groups were trained 5 days per week for 3 weeks. The primary outcome
measure was Fugl-Meyer Assessment-Upper Extremity (FMA-UE) motor score, and the secondary outcomes were Wolf Motor
Function Test-Functional Ability Scale (WMFT-FAS) and Barthel index (BI). The AA group, in comparison to the Control group,
showed significantly greater increases in FMA-UE score (18.0 ± 9.4 versus 7.5 ± 5.5, 𝑝 = 0.002) and WMFT-FAS score (14.1 ± 7.9
versus 6.7 ± 7.8, 𝑝 = 0.025) after 3 weeks of treatment, whereas the increase in BI was not significant (21.2 ± 24.8 versus 13.1 ± 10.7,
𝑝 = 0.292). There were no adverse events. We conclude that arm training using the AA robotic device is safe and able to reduce
motor deficits more effectively than matched conventional arm training in subacute phase of stroke. The study has been registered
at the ClinicalTrials.gov, ID: NCT02729649.
1. Introduction
Stroke is the leading cause of long-term disability in the
industrialized world [1]. Up to 85% of stroke survivors
experience armweakness andonly 20%–56% regain complete
motor function at 3months [2, 3].Not surprisingly, the degree
of recovery in motor function has the greatest impact on
subjective well-being at 1 year after stroke [4].
The main principle of contemporary rehabilitation is a
task-specific practice with a large number of repetitions,
which is a potent stimulus for promoting motor learning
[5, 6]. Studies on the dose-response relationship have shown
that more therapy is associated with better motor recovery.
Nevertheless, conventional treatments are still not delivered
as intensively or frequently as necessary because of the cost,
repetitive strain injuries in patients, and limited availability of
therapists [5].
Various robot-assisted systems have been developed for
enhancing armmotor recovery, including unilateral, bilateral,
proximal arm and distal arm training devices. Robots encour-
age high repetition of movements with minimal supervision
in a highly motivating environment. Robotic devices should
provide therapy relevant to users and conform to the princi-
ples of conventional therapy. They should be easy to set up,
appeal to users, require minimal supervision from therapists,
and ideally be able to assess motor performance and therapy
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outcomes [7, 8]. A recent review concluded that robotic
systems may improve motor control of upper limbs after
stroke but not necessarily increase functional abilities [9].
Despite potential for improving upper limb functions after
stroke, the quality of evidence in support of robot devices
remains low [10].
A few simple and low-cost robotic devices have been
evaluated in stroke patients with moderate arm weakness.
Improvements in kinematic and clinical outcomes were
reported in moderately disabled chronic stroke patients who
participated in a telerehabilitation program using a simple
robotic device [11].The study also found high level of interest,
motivation, and enjoyment among patients with minimal
supervision from the therapist [11].
ArmAssist (AA) is a low-cost robotic system developed
for shoulder and elbow rehabilitation after stroke (TEC-
NALIA R&I, Spain). It is a modular system that combines
a portable device for providing arm support over a table
with interactive games operating on a web-based platform
(Figure 1). The AA does not actively move the arm; instead,
it facilitates active gravity-supported planar arm movements
while measuring several parameters (2D position, orienta-
tion, forearm angle, and arm support/lifting force) used to
control the games. The device is easily attached to the arm by
an adjustable forearm and hand orthosis and is designed to
allow natural arm movements with minimal resistance. The
AA includes games for both training and assessment. The
training games include complex tasks that require variable
cognitive engagement designed to motivate the user to train
longer and more effectively. The examples of training games
include puzzles, memory, language, and card games [12]. The
assessment games are short tasks (1 to 2minutes) that evaluate
different aspects of the upper limb motor control, such as
the range and characteristics of movements with different
degrees of freedom. The AA can be used both at a clinic and
at home, while the therapist can monitor progress and adapt
the therapy accordingly.
The aim of this study was to determine preliminary effi-
cacy of the AA robotic device in comparison to the matched
conventional arm training in subacute stroke patients under-
going rehabilitation.Theprimary outcomemeasurewas Fugl-
Meyer Assessment-Upper Extremity (FMA-UE)motor score,
and the secondary outcomes wereWolfMotor Function Test-
Functional Ability Scale (WMFT-FAS) and Barthel index
(BI).
2. Methods
2.1. Design. We conducted a single-blind (evaluator), two-
arm parallel, randomized controlled trial in subacute stroke
patients with equal allocation to the two groups. The study
was approved by the Ethics Committee of the Clinic for
Rehabilitation “Dr. Miroslav Zotovic´” affiliated with the
Faculty of Medicine, University of Belgrade. The study was
registered at the ClinicalTrials.gov (NCT02729649) prior to
participant enrollment. All participants signed the informed
consent form and all research procedures were performed in
accordance with the Declaration of Helsinki.
2.2. Setting. The study was conducted in a postacute reha-
bilitation hospital (Clinic for Rehabilitation “Dr. Miroslav
Zotovic´,” Belgrade, Serbia).
2.3. Participants. Twenty-six hemiparetic subacute stroke
subjects were recruited for this study between January 2015
andMarch 2016 from the pool ofwaitlisted patients scheduled
for inpatient rehabilitation. During the screening process, all
potential participants were interviewed and examined by the
study investigator with more than 5 years of clinical expe-
rience in neurological rehabilitation. The inclusion criteria
were (a) unilateral paresis as a result of first ischemic or
hemorrhagic stroke confirmed by computed tomography or
MRI that occurred less than 3 months before enrollment,
(b) the ability to understand and follow simple instructions,
and (c) the ability to perform some active movements in the
shoulder and/or elbow joints in the sitting position, allowing
for trunk compensation if needed. The exclusion criteria
were (a) multiple strokes, (b) bilateral impairment, (c) severe
sensory deficits in the paretic upper limb, (d) the inability to
provide informed consent, and (e) medical conditions that
could interfere with treatment (severe cardiovascular dis-
ease, severe visual or auditory impairments, and orthopedic
contracture). Baseline FMA in the participants with severe
motor impairments was ≤25 and in those with moderate
impairments 26 to 50 out of 66 [13]. The participants were
randomized using a table of random numbers (SAS software)
in the AA group (𝑛 = 13) or the Control group (𝑛 = 13).
The sample size calculations were performed using 𝑅
Studio software v. 0.98.976 (Boston, MA, USA), SPSS 17.0
(SPSS Inc., Chicago, IL,USA), andG ∗Power 3.1.Theminimal
clinically important difference for FMA-UE was estimated
previously at 10% of the maximum score (6.6 points) [14] and
adopted here. To achieve at least this difference between the
groups and assuming the alpha level of 0.05 and power of
80%, the estimated sample size was 13 per group.
3. Interventions
3.1. GeneralOverview. TheAAgroup received a conventional
rehabilitation with an additional 30 minutes of the AA
training. The Control group received the same conventional
rehabilitation and an additional 30 minutes of occupational
therapy that was matched in its structure and amount to
the AA training as close as possible. The AA or matched
arm training was administered over 15 sessions each lasting
30 minutes, scheduled 5 days per week (Monday–Friday)
for 3 weeks, at least 24 hours apart, and at about the same
time of day. Both types of arm training were provided by a
physiotherapist with a graduate degree and vast experience
in neurological rehabilitation, who was not involved in the
assessment. The arm training was carried out in the same
therapy room and separated from other treatments by at least
a 30-minute break. To assess adverse events, the subjects were
asked at the end of each session to report any new symptoms.
3.2. Conventional Rehabilitation. The conventional rehabil-
itation was provided 5 days per week for 3 weeks divided
into two 30-minute sessions of occupational therapy and
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Figure 1: ArmAssist training.
physiotherapy. Occupational therapy for the paretic upper
limb included passive stretching within submaximal ranges
of motion to inhibit spasticity, active-assisted movements,
functional tasks, and activities of daily living, all progressed
individually. Physiotherapy consisted of range of motion
exercises for upper and lower extremities, gentle stretching,
splinting/casting, facilitation of active voluntary movement,
and exercises to improve endurance, balance, strength, and
gait. If necessary, speech therapy was provided three to five
times per week.
3.3. ArmAssist Training. The AA training consists of self-
directed active movements through interactive gaming with
focus on reaching. The movements required for playing the
games are horizontal abduction-adduction in the shoulder
and flexion-extension in the elbow with the hand in neutral
position. The number of reaching movements in each game
ranges from 2 to 8 per minute, depending on the cognitive
load of the game. In this study, the subjects performed,
on average, 4–5 repetitions per minute or about 120–150
movements per session.
The subjects were seated in a chair with a back support
and two adjustable shoulder straps to prevent compensatory
trunk movements. The straps were adjusted if necessary to
allow limitedmovement of the trunk for comfort.The subject
was positioned in the semicircular opening of the table (Fig-
ure 1). The chair height was adjusted so the paretic forearm
rests on the AA platform with the shoulder in a comfortable
position. The AA-based assessment of range of motion and
range of force was conducted twice a week (Monday, Friday)
to adjust the game difficulty so the subject is challenged but
still able to successfully complete the virtual task [12].TheAA
robotic system does not have medical certification and has
been used in this study as an investigational device.
3.4. Conventional Arm Training. This training consisted of
exercises mirroring the structure and amount of AA training
as close as possible (Figure 2). The set-up included a chair
with adjustable height, a desk, and a cone. The task was to
move the cone from the starting position to different target
positions (Figure 2), which required horizontal abduction-
adduction movements of the shoulder and flexion-extension
movements of the elbow, similar to the AA training. The
therapist provided assistance as needed and encouraged
participants to complete the tasks. The average number of
performed movements was estimated at 4-5 per minute or
120–150 repetitions per session, as reported by the therapist
and based on the earlier feasibility study conducted in 3
subjects who met the same eligibility criteria.
3.5. Outcome Measures. The primary outcome measure was
FMA-UE motor score, which assesses the degree of syner-
gistic movements in the paretic upper limb. Individual items
pertaining to the shoulder/elbow and hand segments are
scored on a 3-point ordinal scale and summed for amaximum
possible score of 66 [15, 16].
The secondary outcomes were WMFT and BI. The
WMFT is an activity-based test that evaluates upper extrem-
ity performance via timed and functional tasks. Each item
is rated on a 6-point Functional Ability Scale (FAS) and
summed into total WMFT-FAS score. We used a 17-item
WMFT, consisting of 15 function-based tasks and two
strength tasks, each scored from 0 to 5 for a maximum score
of 75 points [17]. The WMFT has shown high reliability and
validity for activity-based evaluation of upper limb function
[18]. The BI assesses activities of daily living. It includes 10
items which are rated based on the amount of assistance
required to complete each activity. The items bathing and
grooming are scored 0 or 5; the items feeding, dressing,
controlling bladder, controlling bowel, getting on and off the
toilet, and ascending and descending stairs are scored 0, 5,
or 10. Items regarding transfer from wheelchair to bed and
walking on a level surface are scored 0, 5, 10, or 15. The total
BI score ranges from 0 (total dependence) to 100 (complete
independence) [19]. The BI has proven reliable for assessing
rehabilitation outcomes after neurological, neuromuscular,
and musculoskeletal diseases [20].
All outcomes were evaluated at baseline and after 3
weeks of intervention by a physiotherapist experienced in
neurological rehabilitation, who was blinded to the group
allocation (independent evaluator).
3.6. Statistical Analysis. Data were analysed using SPSS v17.0
(SPSS Inc., Chicago, IL, USA) and R-studio (2014) v0.98.976
(Boston, MA, USA), following an intention-to-treat analysis
using the last forward method. For descriptive purposes,
the demographics and baseline outcome measures were
compared between the two groups using the independent
sample t-test (continuous data) and Chi-square or Fisher’s
test (categorical data). The main outcome measures did not
deviate significantly from normality (Kolmogorov-Smirnov
test, 𝑝 > 0.05). For the main analysis, the before-after
differences were calculated and compared between the two
groups using the independent sample t-test. The effect size
was calculated usingCohen’s d coefficient (<0.2 small; 0.2–0.8
medium; and >0.8 large) to infer the magnitude of changes.
The level of statistical significance was set at 𝑝 < 0.05 (two-
tailed).
4. Results
Seventy-three consecutive patients from the waitlist were
screened of whom 26 met the eligibility criteria (20 did not
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Figure 2: Conventional arm training.
meet inclusion criteria, 22 were medically unstable, and 5
refused to participate). None of the 26 recruited subjects
dropped out. Figure 3 shows the flow of subjects through all
phases of the study.
There were no significant differences in baseline demo-
graphic and clinical parameters between the two groups
(Tables 1 and 2). No (serious) adverse events were reported.
The changes in primary and secondary outcomes at
the end of treatment are shown in Table 3. There was a
significantly greater increase in FMA-UE score (𝑝 = 0.002)
and FMA-UE shoulder/elbow score (𝑝 = 0.006) in the AA
group compared to the Control group. The improvements
in WFMT-FAS (𝑝 = 0.025) and shoulder/elbow portion of
WFMT (𝑝 = 0.010) were also significantly greater in the AA
group. All effect sizes were large.
5. Discussion
In this study, we compared the efficacy of the AA robotic
arm training against the matched conventional arm training
in subacute stroke patients with moderate-to-severe arm
motor impairment. The results showed that 15 sessions of
the AA training resulted in comparably greater reduction in
the upper limbmotor impairment.The increases in FMA-UE
score in both the AA group (18 points) and the conventional
group (9 points) were greater than the adopted 6.6-point
minimal clinically important difference, suggesting that these
gains may be considered meaningful. Moreover, in contrast
Table 1: Demographic data and baseline clinical characteristics.
AA group Control group 𝑝 value∗
Age (years)1 56.5 ± 7.4 58.3 ± 5.2 0.471
Sex2 0.322
Male 12 (92.3%) 9 (69.2%)
Female 1 (7.7%) 4 (30.8%)
Duration (days)1 35.3 ± 9.7 37.3 ± 7.7 0.566
Affected side2 0.810
Left 5 (38.5%) 6 (46.2%)
Right 8 (61.5%) 7 (53.8%)
Type of stroke2 0.617
Ischemic 12 (92.3%) 11 (84.6%)
Hemorrhagic 1 (7.7%) 2 (15.4%)
NIHSS1 6.1 ± 1.6 6.2 ± 2.2 0.839
NIHSS: National Institute of Health Stroke Scale. 1Mean ± standard devia-
tion. 2Frequency (percentage). ∗Statistically significant (𝑝 < 0.05).
to most of the previous studies that examined outcomes
after robot-assisted arm training [10], our results indicate
significant improvements in functional activities (WMFT-
FAS score) after using the AA device. These findings could
be ascribed to greater reduction in motor impairment, syn-
ergistic effects of the AA therapy and spontaneous recovery,
or better motivation and greater cognitive engagement while
participating in the AA training.
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Figure 3: Study flow diagram.
Table 2: Baseline outcome measures.
AA group Control group 𝑝 value∗
FMA-UE1 26.5 ± 7.7 26.6 ± 7.5 0.980
FMA-UE1 shoulder/elbow 18.5 ± 6.0 18.7 ± 5.2 0.945
WMFT-FAS1 44.2 ± 12.2 42.4 ± 13.3 0.727
WMFT-FAS1 shoulder/elbow 24.5 ± 5.5 22.8 ± 4.9 0.419
BI1 65.0 ± 26.1 65.4 ± 19.8 0.967
FMA-UE: Fugl-Meyer Assessment of Upper Extremity, WMFT-FAS: Wolf
Motor Function Test-Function Ability Scale, BI: Barthel index. 1Mean ±
standard deviation. ∗Statistically significant (𝑝 < 0.05).
Numerous studies have shown benefits of various robotic
devices for improving function of the paretic arm after
stroke. Some earlier studies of the robot-assisted arm therapy
included chronic andmildly disabled stroke patients [9, 10, 21,
22], whereas more recent studies also showed improvements
in subacute patients with moderate-to-severe impairments
[23–25]. Recovery of more impaired patients is usually
limited and requires intensive and motivating therapy, which
the AA device is able to provide.
Our findings are in agreement with the results of pre-
vious studies examining effects of low-cost robotic therapy
during the subacute phase of recovery from stroke. For
example, significant improvements in the upper limb motor
performance, as measured by FMA and the Motricity Index,
were reported after 2 weeks of robot-assisted treatment in
25 subacute stroke patients [8]. Similarly, a randomized
trial of 56 subacute stroke patients with moderate-to-severe
disability showed greater increases in FMA and Motricity
Index after 15 sessions of robot-assisted training compared
to intensive conventional therapy of the same duration [24].
In a single-blind randomized controlled study, Hesse and
colleagues found that 30minutes of robot-assisted arm group
therapy combined with 30 minutes of individual arm therapy
(5 times per week, 4 weeks) was as effective as a double
session of individual arm therapy for reducing the upper limb
motor impairment (FMA) in moderately to severely affected
subacute stroke patients [25].
In contrast to the FMA-UE and WMFT, we found no
significant differences in BI between the two groups.Thismay
be due to a short duration of treatment since BI reflects global
physical abilities, which depend on restoration of many other
functions and associated comorbidities [26]. No significant
difference in BI is consistent with the recent meta-analysis
which found evidence of significant improvements in the
upper limb motor function after upper limb robotic therapy
but no associated changes in the activities of daily living
[9].
The improvements after AA training may be due to
greater engagement and cognitive demands required for
successfully completing virtual gaming tasks. Also, the AA
groupwas required to convertmotor action into visual spatial
coordinates through interactions with the computer screen.
Increased cognitive demandswere found tomodulate activity
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Table 3: Changes in outcome measures from the period before to the period after the treatment.
Outcome measure AA group Control group 𝑝 𝑑
FMA-UE1 18.0 ± 9.4 7.5 ± 5.5 0.002 ∗ 1.909
FMA-UE1 shoulder/elbow 9.1 ± 6.3 3.4 ± 2.6 0.006 ∗ 2.192
WMFT-FAS1 14.1 ± 7.9 6.7 ± 7.8 0.025 ∗ 0.949
WMFT-FAS1 shoulder/elbow 6.7 ± 7.8 3.2 ± 2.7 0.010 ∗ 1.185
BI1 21.2 ± 24.8 13.1 ± 10.7 0.292 —
FMA-UE: Fugl-Meyer Assessment of Upper Extremity.WMFT:WolfMotor Function Test. BI: Barthel Index. Effect size Cohen’s 𝑑 (<0.2 small; 0.2–0.8medium;
and >0.8 large). 1Mean ± standard deviation. ∗Statistically significant (𝑝 < 0.05).
in multiple brain motor networks and may enhance motor
learning [27].
This study has several limitations consistent with its pre-
liminary nature. We did not consider other factors that could
have influenced the outcomes, such as type and location of
stroke, motivation, and cognitive abilities. Also, we were able
to report an approximate number of repetitions only, whereas
the two training protocols were closely matched on several
other characteristics of executed movements, such as the
type (reaching), plane of action (horizontal), goal (aiming for
targets), and constraints (self-directed). No reports of even
mild adverse events (e.g., fatigue) with the AA training may
reflect an interviewer or response bias. Another limitation
is a lack of follow-up to determine durability of effects.
Contextual factors such as patient and caregiver impressions
should be evaluated in the future. Finally, kinematic analyses
are necessary to distinguish improved performance due to
arm motor recovery from compensatory movements.
6. Conclusions
Arm training using the AA robotic device reduced impair-
ment and activity-relatedmotor deficits more effectively than
matched conventional arm training in subacute phase of
recovery from stroke.There were no (serious) adverse events.
These preliminary results support further research aimed at
identifyingmost suitable candidates andmost optimal timing
of the AA robotic training as well as feasibility and potential
benefits of administration in home settings.
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